The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure
Open accessAbstract
The evaluation and use of patient reported outcome (PRO) measures requires detailed understanding of the meaning of the outcome of interest. The Food and Drug Administration (FDA) recently presented its draft guidance and view on the use of PRO measures as endpoints in clinical trials. One section of the guidance document specifically deals with advice about the use of the minimal important difference (MID) that we redefined as the smallest difference in score in the outcome of interest that informed patients or informed proxies perceive as important. The advice, however, is short, indeed much too short. We believe that expanding the section and making it more specific will benefit all stakeholders: patients, clinicians, other clinical decision makers, those designing trials and making claims, payers and the FDA. There is no "gold standard" methodology of estimating the MID or achieving the meaningfulness of clinical trial results based on patient reported outcomes. There are many methods of estimating the MID usually grouped into two distinct categories: anchor-based methods, that examine the relationship between scores on the target instrument and some independent measure, and distribution-based methods resorting to the statistical characteristics of the obtained scores. Estimation of an MID and interpretation of clinical trial results that present patient important outcomes is demanding but vital for informing the decision to recommend approve a given intervention. Investigators are encouraged to use reliable and valid methods to achieve meaningfulness of their results, preferably those that rely on patients to estimate what constitutes a minimal important, small, moderate, or large difference. However, acquiring the meaningfulness of PRO measures transcends beyond a concept of the MID and we advocate that dichotomizing the scores of patient-reported outcome measures facilitate interpretability of clinical trial results for those who need to understand trial results after a labelling claim has been granted. Irrespective of the strategy investigators use to estimate these values, from the individual patient perspective it is much more relevant if investigators report both the estimated thresholds and the proportion of patients achieving that benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Self-rated health and mortality in the NHANES I Epidemiologic Follow-up Study
Idler, E. L., & Angel, R. J. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.4.446 · Cited by 864
Interpreting treatment effects in randomised trials
Guyatt, G. H., Juniper, E. F., Walter, S. D., Griffith, L. E., & Goldstein, R. S. (1998) · BMJ · doi:10.1136/bmj.316.7132.690 · Cited by 516
Self-citationLife quality of patients with chronic obstructive pulmonary disease
McSweeny, A. J. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340160057014 · Cited by 490
Speer, D. C., & Greenbaum, P. E. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.6.1044 · Cited by 216
Cited by
Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., Schwartz, C., Revicki, D. A., Moinpour, C. M., McLeod, L. D., et al. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0344-y · Cited by 845
Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J.-S., Terluin, B., Cella, D., Griffiths, P., & Mokkink, L. B. (2021) · Quality of Life Research · doi:10.1007/s11136-021-02925-y · Cited by 556
Tashjian, R. Z., Hung, M., Keener, J. D., Bowen, R. C., McAllister, J., Chen, W., Ebersole, G., Granger, E. K., & Chamberlain, A. M. (2017) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2016.06.007 · Cited by 420
Tubach, F., Ravaud, P., Martin‐Mola, E., Awada, H., Bellamy, N., Bombardier, C., Felson, D. T., Hajjaj‐Hassouni, N., Hochberg, M., Logeart, I., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21747 · Cited by 416
The Development, Assessment, and Selection of Questionnaires
PESUDOVS, K., BURR, J. M., HARLEY, C., & ELLIOTT, D. B. (2007) · Optometry and Vision Science · doi:10.1097/opx.0b013e318141fe75 · Cited by 403
Metadata
- Authors
- Brożek, J. L., Guyatt, G. H., & Schünemann, H. J.
- Venue
- Health and Quality of Life Outcomes
- Published
- 2006-09-27
- Volume
- 4
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1477-7525 (ISSN-L)
- OpenAlex
- W1924063373
- Cited by
- 174
- References
- 7
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. https://app.cochat.ai/papers/10.1186/1477-7525-4-69
- The paper
- Brożek, J. L., Guyatt, G. H., & Schünemann, H. J. (2006). How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health and Quality of Life Outcomes. https://doi.org/10.1186/1477-7525-4-69
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.